USIL Therapeutics is a biotechnology company focused on radiological preparedness.
USIL Therapeutics has raised $6.1M in total funding. The most recent round was Grant. The last funding was announced in May 2026.
USIL Therapeutics's investors include European Commission.
USIL Therapeutics is headquartered in Luxembourg, Luxembourg.
USIL Therapeutics is a biotechnology company focused on radiological preparedness.
USIL Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"USIL Therapeutics — Funding & Investors." VCBacked, May 5, 2026, https://www.vcbacked.co/company/usil-therapeutics. Accessed October 8, 2026.
VCBacked. (2026). USIL Therapeutics — Funding & Investors. Retrieved October 8, 2026, from https://www.vcbacked.co/company/usil-therapeutics
{{cite web |title=USIL Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/usil-therapeutics |website=VCBacked |access-date=October 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated